BIBDX
Price
$13.60
Change
+$0.08 (+0.59%)
Updated
Dec 3 closing price
Net Assets
934.15M
LSVGX
Price
$17.64
Change
+$0.12 (+0.68%)
Updated
Dec 3 closing price
Net Assets
93.23M
Interact to see
Advertisement

BIBDX vs LSVGX

Header iconBIBDX vs LSVGX Comparison
Open Charts BIBDX vs LSVGXBanner chart's image
BlackRock Global Dividend Instl
Price$13.60
Change+$0.08 (+0.59%)
VolumeN/A
Net Assets934.15M
LSV Global Value Institutional
Price$17.64
Change+$0.12 (+0.68%)
VolumeN/A
Net Assets93.23M
BIBDX vs LSVGX Comparison Chart in %
View a ticker or compare two or three
VS
BIBDX vs. LSVGX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIBDX is a Buy and LSVGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BIBDX has more cash in the bank: 934M vs. LSVGX (93.2M). LSVGX pays higher dividends than BIBDX: LSVGX (2.16) vs BIBDX (1.19). BIBDX was incepted earlier than LSVGX: BIBDX (18 years) vs LSVGX (11 years). LSVGX (1.05) is less costly to investors than BIBDX (0.80). BIBDX is a more actively managed with annual turnover of: 44.00 vs. LSVGX (12.00). LSVGX has a lower initial minimum investment than BIBDX: LSVGX (100000) vs BIBDX (2000000). LSVGX annual gain was more profitable for investors over the last year : 15.04 vs. BIBDX (3.47). LSVGX return over 5 years is better than : 74.54 vs. BIBDX (16.78).
BIBDXLSVGXBIBDX / LSVGX
Total Expense Ratio0.800.9089%
Annual Report Gross Expense Ratio0.801.0576%
Fund Existence18 years11 years-
Gain YTD14.28323.42561%
Front LoadN/AN/A-
Min. Initial Investment20000001000002,000%
Min. Initial Investment IRAN/AN/A-
Net Assets934M93.2M1,002%
Annual Yield % from dividends1.192.1655%
Returns for 1 year3.4715.0423%
Returns for 3 years32.3449.3666%
Returns for 5 years16.7874.5423%
Returns for 10 years36.43121.6530%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMOPF81.79N/A
N/A
Cosmo Pharmaceuticals NV
GMVHF10.65N/A
N/A
ENTAIN PLC
KBCSF119.42N/A
N/A
KBC Group SA
PRVCF0.02N/A
N/A
PreveCeutical Medical Inc.
IRCDF1.37N/A
N/A
Intercede Group PLC